Janjua, N Z <br/><br/>
Shift in disparities in hepatitis C treatment from interferon to DAA era: A population-based cohort study.  [electronic resource] 

 -  Journal of viral hepatitis  08 2017 
 - 624-630 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2893 
<br/><br/><label>Standard No.: </label>10.1111/jvh.12684  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antiviral Agents--therapeutic use<br/>British Columbia<br/>Cohort Studies<br/>Female<br/>Healthcare Disparities<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferons--therapeutic use<br/>Male<br/>Middle Aged<br/>Oligopeptides--therapeutic use<br/>Proline--analogs & derivatives<br/>Ribavirin--therapeutic use<br/>Young Adult